Key result
Transapical TAVI plus tricuspid TEER eliminates AS and reduces TR, improving heart failure symptoms.
Case Report (n=1)
No
Transcatheter mitral valve edge-to-edge repair using the MitraClip system (Abbott Vascular, USA) and transcatheter aortic valve implantation (TAVI) are well established in high-risk or inoperable patients with severe mitral regurgitation and severe aortic stenosis. The benefits of both methods have been confirmed in large cohort studies [1–4]. Recently, successful transcatheter tricuspid valve edge-to-edge repair using the MitraClip system was described for high surgical risk or inoperable patients [5–7].
No takes yet. Share an insight, caveat, or question.
Kowalski et al. (2016) conducted a case report in Significant aortic stenosis and severe tricuspid valve regurgitation (n=1). Transapical TAVI and transfemoral tricuspid valve edge-to-edge repair (MitraClip) was evaluated on Clinical and echocardiographic improvement. Transapical TAVI followed by transfemoral tricuspid valve edge-to-edge repair using the MitraClip system successfully eliminated aortic stenosis and reduced tricuspid regurgitation, improving heart failure symptoms.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: